English English Engineered to satisfy stringent European Pharmacopoeia and EFSA criteria, our standardized bioactive ingredients deliver unmatched batch-to-batch homogeneity for contract manufacturers, nutraceutical laboratories, and sports nutrition formulators.
Exploring the pharmacokinetics of Menaquinone-7 (MK-7) versus MK-4, isomeric integrity in mineral matrixes, and precision bio-fermentation protocols tailored for industrial procurement officers.
The biological efficacy of Vitamin K2 MK7 depends entirely on its steric configuration. Only the All-Trans isomer fits the binding site of gamma-glutamyl carboxylase, the hepatic and extrahepatic enzyme that activates osteocalcin and Matrix Gla Protein (MGP).
Synthetic routes frequently produce up to 15-30% inactive cis-isomers. BKYULA Biotech utilizes a proprietary deep fermentation method using Bacillus subtilis var. natto coupled with supercritical carbon dioxide (scCO2) fractionated extraction, guaranteeing an all-trans MK-7 purity exceeding 99.5% confirmed via Chiral HPLC.
While Vitamin K2 MK4 features a short systemic half-life (approx. 1.5 to 3 hours), requiring mega-dosages (45 mg/day), naturally fermented MK-7 exhibits a 72-hour half-life in human blood serum.
This extended half-life allows sustained circulating levels, ensuring continuous carboxylation of vascular MGP to inhibit arterial calcification while simultaneously directing bioavailable calcium ions straight into the hydroxyapatite matrix of skeletal bone tissues with microgram dosages (45–180 mcg/day).
Unprotected MK-7 degrades rapidly in the presence of alkaline mineral compounds such as Calcium Carbonate, Calcium Citrate, and Magnesium Oxide. Standard unformulated powders can experience over 70% active loss within six months of shelf-life.
BKYULA Biotech has formulated double-coated microencapsulated MK-7 beadlets using pharmaceutical-grade hydrocolloids. This micro-shield insulates the menaquinone core from ambient humidity, light, and mechanical tableting pressure, preserving active assay stability beyond 36 months.
| Analytical Parameter | Natural Fermented MK-7 Powder | Microencapsulated MK-7 Beadlets | Oil Grade (MCT / Olive Oil Base) |
|---|---|---|---|
| Assay Concentration | 1,000 ppm to 10,000 ppm (0.1% - 1.0%) | 1,000 ppm to 20,000 ppm (0.1% - 2.0%) | 1,500 ppm to 50,000 ppm |
| Stereochemical Conformation | >99.0% All-Trans Menaquinone-7 | >99.5% All-Trans Menaquinone-7 | >99.0% All-Trans Menaquinone-7 |
| Carrier System | Maltodextrin / Acacia Fiber | Modified Starch, Sucrose, MCT Core | Medium Chain Triglycerides (Non-GMO) |
| Target Formulation | Standard Capsules, Dry Powder Blends | Direct Compression Tablets, Multiminerals | Softgels, Liquid Droppers, Functional Fats |
| Solvent Residues | None (Supercritical scCO2 Process) | Complies with EP / USP limits | Solvent-Free Separation |
| Heavy Metals (Pb, As, Cd, Hg) | <1.0 ppm total (ICP-MS Verified) | <1.0 ppm total (ICP-MS Verified) | <0.5 ppm total (ICP-MS Verified) |
Situated within the Upper Rhine Valley’s biopharmaceutical corridor, manufacturers in Schaan and across the Principality of Liechtenstein represent the highest standard of international life sciences manufacturing. Here is how BKYULA Biotech supports these specialized requirements.
Liechtenstein’s advanced contract packers and CDMOs develop high-end solid oral dosage formats for export across Switzerland, Austria, and Germany (DACH region). Our microencapsulated MK-7 powder provides outstanding mechanical resilience under high-speed rotary tablet presses.
Free-flowing, non-clumping bulk powders ensure uniform content across multi-vitamin-mineral blends, eliminating batch stratification and passing uniform content validation under European Pharmacopoeia (Ph. Eur.) guidelines.
Local research teams capitalize on the validated clinical synergy between Vitamin D3, Vitamin K2 MK7, and bioactive marine minerals. Modern formulations require exact microgram stability to support EFSA health claims under Article 13/14.
BKYULA Biotech supplies high-stability active batches verified by dual-column HPLC assays, preventing cross-catalytic oxidation when blended with acidic fruit powders or reactive calcium salts.
Liechtenstein’s unique regulatory setup—being an EEA member state while sharing a customs treaty and currency union with Switzerland—demands comprehensive documentation. Products must conform simultaneously to EU regulations and Swiss Federal Food Safety and Veterinary Office (FSVO/BLV) thresholds.
Every BKYULA Biotech consignment is backed by full analytical documentation: BSE/TSE-free attestations, Non-GMO verification, allergen declarations, residual solvent testing, and irradiation-free certificates.
BKYULA Biotech operates over 15,000 square meters of cGMP-compliant manufacturing infrastructure. Equipped with multi-stage stainless extraction vessels, vacuum concentration stations, and advanced analytical instrumentation, our facility ensures full supply chain traceability from raw biomass to sealed drums.
Automated stainless steel bioreactors with real-time temperature, pH, and dissolved oxygen regulation, delivering standardized metabolic yields of pure MK-7.
In-house Shimadzu and Agilent HPLC systems quantify all-trans versus cis isomeric ratios on every lot prior to commercial release.
Low-temperature spray drying and fluid-bed coating protect delicate heat-sensitive menaquinone chains from oxidative degradation.
Essential guidance on minimum order quantities, stability testing protocols, customs procedures for Liechtenstein, and full analytical batch documentation.
For standard powdered plant extracts and bulk functional ingredients, our MOQ begins at 1 kg. For high-potency Vitamin K2 MK7 active powders (such as pure 1% or 0.2% standardized grades) and cosmetic-grade PDRN, trial shipments start from 100 grams to support pilot formulation testing, scale-up runs, and analytical validation.
Liechtenstein participates in a customs union with Switzerland. We routinely provide DDP (Delivered Duty Paid), DAP, and CIF Zurich air freight arrangements via DHL, FedEx, or air cargo. All freight is accompanied by customized commercial invoices, packing lists, and export declarations formatted to clear Swiss customs at Zurich Airport (ZRH) or Basel without clearance delays.
Every commercial batch is supplied with an official Certificate of Analysis (COA) specifying HPLC quantitative assay values, stereochemical isomer breakdown (all-trans %), loss on drying, sieve mesh size, heavy metal panel (Pb, Cd, As, Hg by ICP-MS), and microbiological analysis (TAMC, TYMC, Salmonella, E. coli). Complete MSDS, flow charts, and Non-GMO attestations are provided prior to dispatch.
Direct exposure to alkaline minerals (e.g., Magnesium Oxide, Calcium Carbonate) triggers rapid ring-opening degradation in unprotected menaquinone. For multimineral tablets and effervescent formulations produced in Schaan, we supply microencapsulated beadlets with double cross-linked hydrocolloid protective walls, maintaining active potency through accelerated stability testing (40°C / 75% RH for 6 months).
Yes. Our automated processing plant supports custom pulverization from 80 to 200 mesh. We offer tailored carrier matrices including organic maltodextrin, gum acacia, non-GMO corn starch, or direct oil suspensions (USP-grade MCT or extra virgin olive oil), configured precisely to match your blending equipment and encapsulation lines.
We support T/T bank transfer, confirmed irrevocable Letters of Credit (L/C), and secure digital escrow in USD and EUR. BKYULA Biotech maintains an open-door policy for international buyers, welcoming third-party onsite facility inspections (such as SGS or client-appointed European quality auditors) to verify raw material custody and QA protocols.